Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases

Eiko N Minakawa1, Yoshitaka Nagai1,2

  • 1Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan.